Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-037263
Filing Date
2025-10-03
Accepted
2025-10-03 18:24:41
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3768
  Complete submission text file 0001140361-25-037263.txt   5416
Mailing Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183
Business Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 49 89 2153 9035
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183
Business Address
Barrett Christopher Ryan Cave (Reporting) CIK: 0002087548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 251375289